π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Based on different HR status, we explored the efficacy and safety of Pyroti...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-05-20
Trial ID
NCT05328440
Treatments Being Tested
The purpose of this study is to determine if the triplet combination of dal...
Status
Unknown
Location
Tianjin Cancer Hospital
Start Date
2023-05
Trial ID
NCT05806671
Treatments Being Tested
The objective of this study is to evaluate the efficacy of combination of p...
Status
Unknown
Location
Shusen Wang
Start Date
2020-12-04
Trial ID
NCT04334330
Treatments Being Tested
The prognosis of young patients with breast cancer is relatively poor. Chem...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-08-01
Trial ID
NCT06027541
Treatments Being Tested
This is a single-center Ib / II study of triple targeted drug combination (...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-05-12
Trial ID
NCT03772353
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER1, HER2 an...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2018-11-01
Trial ID
NCT04033172
Treatments Being Tested